TrialGlobe

Clinical trial

Chinese, Overweight or Obesity, Real-World Registry Study

Opening soon · Not applicable · 1 countries · Registry ID NCT07525037

Opening soonNot applicableObservational

What this study is about

This study will enroll 10,000 patients with obesity, with the participation of approximately 50 medical institutions nationwide. At baseline, demographic data, physical examinations, multiple laboratory tests (including complete blood count, urinalysis, liver/renal function, electrolytes, thyroid function panel \[3 items\], urine albumin/creatinine ratio, fasting glucose, fasting C-peptide, fasting insulin, HbA1c, blood lipids, etc.) and hepatic elasticity ultrasound will be performed. Patients will receive weight-loss therapy in routine clinical practice. Data on clinic visits, adverse events, and changes in therapeutic regimens will be centrally collected by investigators or their authorized representatives at Week 26 and Week 52.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

AgeNot listed to Not listed
SexAll
Healthy volunteersNot accepted
ConditionObesity Type 2 Diabetes Mellitus

Full registry criteria

Inclusion Criteria: According to local regulations, the subjects included in the study should meet the following criteria: 1. Male or female patients aged 18 years or above 2. Diagnosed with overweight or obesity, with a BMI of ≥ 24 kg/m² 3. Willing and able to use weight management apps 4. Willing and able to provide a written informed consent for participating in the study 5. Patients who meet the instructions for weight loss medication and have no contraindications to non-pharmacological treatments - Exclusion Criteria: 1. Having life-threatening comorbidities, with an expected lifespan of less than one year. 2. Participating in an interventional trial that requires informed consent. 3. Engaging in other organized weight loss programs or other clinical trials. 4. Researchers identify any situation that may endanger the safety or compliance of the subjects. \-

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

The treatment model for overweight and obese individuals in China at present.1 year

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Chinese PLA General Hospital🇨🇳 Haidian, Being, China
Open map
ChenKangContact
Email · Call 010-55499401